Direkt Links to important GMP Biologic Guidelines

FDA Guidance for Industry: On the Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for an Allergenic Extract or Allergen Patch Test

This document provides guidance on the content and format of the Chemistry, Manufacturing, and Controls (CMC) section of a Biologics License Application for an Allergenic Extract or Allergen Patch Test.

more

FDA Guidance for Industry: Biological Product Deviation Reporting for Blood and Plasma Establishments

Recommendations for Reporting of BPD (Biological Product Deviation)

more

FDA Guidance for Industry: Bar Code Label Requirements, Questions and Answers

Question and answers to the topic of Bar Code Labeling of biological products

more

FDA Guidance for Industry Monoclonal Antibodies Used as Reagents in Drug Manufacturing

This guidance is intended to provide recommendations to sponsors and applicants on the use of monoclonal antibodies(mAbs) as reagents in the manufacture of drug substances 2 that are regulated by the Center for Drug Evaluation and Research (CDER) or the Center for Biologics Evaluation and Research(CBER). The guidance focuses on the chemistry, manufacturing, and control (CMC) issues that should be addressed in new drug applications(NDAs), abbreviated new drug applications (ANDAs), biologics license applications(BLAs), supplements to these applications, or investigational new drug applications (INDs).

more

FDA Guidance for Industry Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for a Biological In Vitro Diagnostic Product

This document is intended for use by those firms which manufacture any licensed in vitro diagnostics used to screen donor blood, determine donor suitability, test for retroviral infection, or determine transfusion compatibility.

more

FDA Guidance for Industry For the Submission of Chemistry, Manufacturing and Controls and Establishment Description Information for Human Plasma- Derived Biological Products, Animal Plasma or Serum-Derived Products

This document provides guidance on the content and format of the Chemistry, Manufacturing and Controls (CMC) section and the Establishment Description section of a Biologics License Application for a Human Plasma-Derived Biological Product, Animal Plasma or Serum-Derived Product.

more

FDA Points to Consider in the Characterization of Cell Lines Used to Produce Biologicals

Xenotranplantation Products - Points to Consider in the Characterization of Cell Lines Used to Produce Biologicals

more

FDA COMPLIANCE PROGRAM GUIDANCE MANUAL Inspection of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) 7341.002

Compliance Program CBER Biologics

more

FDA Compliance Program Chapter 41 - Therapeutic Products Inspection of Tissue Establishments 7341.002A

Compliance Program CBER Biologics

more

FDA Compliance Program Guidance Manual Chapter 42 - Blood and Blood Products Inspection of Licensed and Unlicensed Blood Banks, Brokers, Reference Laboratories, and Contractors- 7342.001

Compliance Program CBER Biologics

more

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK